Total and high-molecular-weight adiponectin and resistin in relation to the risk for type 2 diabetes in women

被引:172
作者
Heidemann, Christin
Sun, Qi
van Dam, Rob M.
Meigs, James B.
Zhang, Cuilin
Tworoger, Shelley S.
Mantzoros, Christos S.
Hu, Frank B.
机构
[1] Harvard Univ, Sch Publ Hlth, Massachusetts Gen Hosp, Brigham & Womens Hosp, Boston, MA 02215 USA
[2] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA
[3] NIH, Bethesda, MD 20892 USA
关键词
D O I
10.7326/0003-4819-149-5-200809020-00005
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Adiponectin and resistin are recently discovered adipokines that may provide a molecular link between adiposity and type 2 diabetes. Objective: To evaluate whether total and high-molecular-weight adiponectin and resistin are associated with future risk for type 2 diabetes, independent of obesity and other known diabetes risk factors. Design: Prospective, nested, case - control study. Setting: United States. Participants: 1038 initially healthy women of the Nurses' Health Study who developed type 2 diabetes after blood sampling (1989 to 1990) through 2002 and 1136 matched control participants. Measurements: Plasma concentrations of total and high-molecular-weight adiponectin and resistin. Results: In multivariate models including body mass index, higher total and high-molecular-weight adiponectin levels were associated with a substantially lower risk for type 2 diabetes (odds ratio [OR] comparing the highest with the lowest quintiles, 0.17 [95% CI, 0.12 to 0.25] for total adiponectin and 0.10 [CI, 0.06 to 0.15] for high-molecular-weight adiponectin). A higher ratio of high-molecular-weight to total adiponectin was associated with a statistically significantly lower risk even after adjustment for total adiponectin (OR, 0.45 [CI, 0.31 to 0.65]). In the multivariate model without body mass index, higher resistin levels were associated with a higher risk for diabetes (OR, 1.68 [CI, 1.25 to 2.25]), but the association was no longer statistically significant after adjustment for body mass index (OR, 1.28 [CI, 0.93 to 1.76]). Limitation: The findings apply mainly to white women and could be partly explained by residual confounding from imperfectly measured or unmeasured variables. Conclusion: Adiponectin is strongly and inversely associated with risk for diabetes, independent of body mass index, whereas resistin is not. The ratio of high-molecular-weight to total adiponectin is related to risk for diabetes independent of total adiponectin, suggesting an important role of the relative proportion of high-molecular-weight adiponectin in diabetes pathogenesis.
引用
收藏
页码:307 / W66
页数:13
相关论文
共 48 条
[1]   Adipose tissue as an endocrine organ [J].
Ahima, Rexford S. .
OBESITY, 2006, 14 :242-249
[2]   NEW LOOK AT STATISTICAL-MODEL IDENTIFICATION [J].
AKAIKE, H .
IEEE TRANSACTIONS ON AUTOMATIC CONTROL, 1974, AC19 (06) :716-723
[3]   Serum resistin, adiposity and insulin resistance in Saudi women with type 2 diabetes mellitus [J].
Al-Harithy, RN ;
Al-Ghamdi, S .
ANNALS OF SAUDI MEDICINE, 2005, 25 (04) :283-287
[4]  
[Anonymous], MODERN EPIDEMIOLOGY
[5]   Obesity, adiponectin and inflammation as predictors of new-onset diabetes mellitus after kidney transplantation [J].
Bayes, B. ;
Granada, M. L. ;
Pastor, M. C. ;
Lauzurica, R. ;
Salinas, I. ;
Sanmarti, A. ;
Espinald, A. ;
Serra, A. ;
Navarro, M. ;
Bonal, J. ;
Romero, R. .
AMERICAN JOURNAL OF TRANSPLANTATION, 2007, 7 (02) :416-422
[6]   Total and high-molecular weight adiponectin in relation to metabolic variables at baseline and in response to an exercise treatment program -: Comparative evaluation of three assays [J].
Blueher, Matthias ;
Fasshauer, Mathias ;
Brennan, Aoife M. ;
Kralisch, Susan ;
Kelesidis, Theodoros ;
Williams, Catherine J. ;
Kratzsch, Juergen ;
Mantzoros, Christos S. .
DIABETES CARE, 2007, 30 (02) :280-285
[7]   Regulation of adiponectin by adipose tissue-derived cytokines: in vivo and in vitro investigations in humans [J].
Bruun, JM ;
Lihn, AS ;
Verdich, C ;
Pedersen, SB ;
Toubro, S ;
Astrup, A ;
Richelsen, B .
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2003, 285 (03) :E527-E533
[8]   Plasma resistin, insulin concentration in non-diabetic and diabetic, overweight/obese Thai [J].
Chanchay, Siriporn ;
Tungtrongchitr, Rungsunn ;
Harnroongroj, Talabporn ;
Phonrat, Benjaluck ;
Rungseesakorn, Orapin ;
Paksanont, Suporn ;
Pooludong, Somchai ;
Selowakontha, Sastri ;
Varongchayakul, Chusak .
INTERNATIONAL JOURNAL FOR VITAMIN AND NUTRITION RESEARCH, 2006, 76 (03) :125-131
[9]   Adiponectin: More than just another fat cell hormone? [J].
Chandran, M ;
Phillips, SA ;
Ciaraldi, T ;
Henry, RR .
DIABETES CARE, 2003, 26 (08) :2442-2450
[10]   Serum adiponectin concentrations predict the developments of type 2 diabetes and the metabolic syndrome in elderly Koreans [J].
Choi, KM ;
Lee, J ;
Lee, KW ;
Seo, JA ;
Oh, JH ;
Kim, SG ;
Kim, NH ;
Choi, DS ;
Baik, SH .
CLINICAL ENDOCRINOLOGY, 2004, 61 (01) :75-80